On-Demand Webinar: High-Quality, Phase-Appropriate Plasmid Manufacturing to Accelerate Advanced Therapies
Three of the biggest plasmid challenges faced by advanced therapies companies are long lead times, ensuring continuity and consistency during early stages of development through commercialization, and variable quality and yield. Choosing a phase-appropriate plasmid manufacturing strategy is crucial to navigating these challenges with speed and quality.
This webinar will provide best-in-class strategies for plasmid development & manufacturing to accelerate advanced therapies from bench to bedside. CBM experts will cover off-the-shelf plasmids to fully customized solutions for a wide range of research, preclinical, clinical, and commercial applications, all confirmed with next-generation sequencing (NGS) to ensure the best source of starting material based on the development stage of any advanced therapy program.
Cell & gene therapy developers will learn:
- – How a platform manufacturing process delivers superior quality plasmids
- – What phase-appropriate grades should be used for pre-clinical through commercial purposes
- – Benefits and tradeoffs of using off-the-shelf vs custom constructs during development
- – Examples of NGS confirmation detecting variants down to 5%
Learn more about CBM’s plasmid DNA manufacturing services here.